Adverse reactions due to monoclonal antibodies in the treatment of allergic diseases. Group Positioning: Comité de Alergia a Medicamentos del Colegio Mexicano de Inmunología Clínica y Alergia (CMICA 2024-2025). (2025). Revista Alergia México, 72(1), 52-71. https://doi.org/10.29262/fsaxnm03